ADVANCED SOLID TUMOR (PHASE 1)
Clinical trials for ADVANCED SOLID TUMOR (PHASE 1) explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOR (PHASE 1) trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOR (PHASE 1), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink hard-to-treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called APX-343A, given alone or with an immunotherapy (pembrolizumab), in people with advanced solid tumors that have not responded to other treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink …
Matched conditions: ADVANCED SOLID TUMOR (PHASE 1)
Phase: PHASE1 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 12:01 UTC
-
New pill hopes to tame advanced cancers
Disease control Recruiting nowThis early-stage trial tests an experimental oral drug called EP102 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and understand how the drug works in the body. About 48 participants with specific cance…
Matched conditions: ADVANCED SOLID TUMOR (PHASE 1)
Phase: PHASE1 • Sponsor: Epics Therapeutics • Aim: Disease control
Last updated May 20, 2026 11:55 UTC